India's first mRNA vaccine HGCO19 received DCGI nod for Phase II/III clinical trials on Tuesday. The Covid-19 vaccine has been developed by Gennova Biopharmaceuticals Ltd, a Pune-based biotechnology company in partnership with the Department of Biotechnology.
Published 24 August 2021, 10:49 IST